These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2521296)

  • 1. A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation.
    Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D
    Cancer; 1989 Jan; 63(2):233-7. PubMed ID: 2521296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
    Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
    Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined 5-fluorouracil and floxuridine administered as a 14-day infusion. A phase I study.
    Anderson N; Lokich J; Bern M; Wallach S; Moore C; Williams D; Umprayn V
    Cancer; 1989 Mar; 63(5):825-7. PubMed ID: 2521571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer.
    Kelsen DP; Saltz L; Cohen AM; Yao TJ; Enker W; Tong W; Tao Y; Bertino JR
    Cancer; 1994 Oct; 74(8):2224-33. PubMed ID: 7922973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorodeoxyuridine with continuous leucovorin infusion. A phase II clinical trial in patients with metastatic colorectal cancer.
    Levin RD; Gordon JH
    Cancer; 1993 Nov; 72(10):2895-901. PubMed ID: 8221555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial.
    Lokich J; Anderson N; Bern M; Coco F; Zipoli T; Moore C; Gonsalves L
    Cancer; 1991 Aug; 68(4):744-6. PubMed ID: 1855174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin.
    Lorenz M; Hottenrott C; Maier P; Reimann M; Inglis R; Encke A
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):163-70. PubMed ID: 1532672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV
    J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical trial with floxuridine and high-dose continuous infusion of leucovorin calcium.
    Levin RD; Gordon JH; Simonich W; Mellijor A; Sanchez R; Williams RM
    J Clin Oncol; 1991 Jan; 9(1):94-9. PubMed ID: 1824639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Steinberg SM; Hamilton JM; Murphy RF; Drake J; Chisena T; Balis F; Cysyk R; Arbuck SG
    Cancer Res; 1993 Oct; 53(20):4828-36. PubMed ID: 8402669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of 5-day continuous infusion fluorodeoxyuridine and high-dose folinic acid with oral hydroxyurea.
    Raschko JW; Akman SA; Leong LA; Margolin KA; Morgan RJ; Newman E; Somlo G; Ahn C; Doroshow JH
    Cancer Chemother Pharmacol; 1994; 35(2):161-4. PubMed ID: 7987994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study.
    Vokes EE; O'Brien SM; Vogelzang NJ; Schilsky RL; Ratain MJ
    Cancer Chemother Pharmacol; 1993; 32(5):347-52. PubMed ID: 8339384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
    Lorenz M; Müller HH
    J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Fluorouracil and methotrexate administered simultaneously as a continuous infusion. A phase I study.
    Lokich JJ; Phillips D; Green R; Paul S; Sonneborn H; Zipoli TE; Curt G
    Cancer; 1985 Nov; 56(10):2395-8. PubMed ID: 4042072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous 5-fluorouracil infusion and pulse methotrexate/leucovorin for colorectal adenocarcinoma. A report of excessive toxicity.
    Hansen RM; Quebbeman EJ; Ritch PS; Frick J; Anderson T
    Am J Clin Oncol; 1987 Jun; 10(3):216-8. PubMed ID: 3496002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant.
    Meropol NJ; Rustum YM; Creaven PJ; Blumenson LE; Frank C
    Cancer Invest; 1999; 17(1):1-9. PubMed ID: 10999043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of phosphonacetyl-L-aspartate, 5-fluorouracil, and leucovorin in patients with advanced cancer.
    Hageboutros A; Rogatko A; Newman EM; McAleer C; Brennan J; LaCreta FP; Hudes GR; Ozols RF; O'Dwyer PJ
    Cancer Chemother Pharmacol; 1995; 35(3):205-12. PubMed ID: 7805178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma.
    Grem JL; McAtee N; Murphy RF; Hamilton JM; Balis F; Steinberg S; Arbuck SG; Setser A; Jordan E; Chen A
    J Clin Oncol; 1994 Mar; 12(3):560-8. PubMed ID: 8120554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infusion of floxuridine plus etoposide plus cisplatin in human malignancies.
    Lokich J; Moore C; Anderson N; Bern M
    Eur J Cancer; 1991; 27(12):1593-6. PubMed ID: 1838261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.